Evidence map›Paper›PMID 40082607›Full record

ArticleScientific reports2025

Identification of candidate biomarkers correlated with the pathogenesis of breast cancer patients.

Shiqun Yu, Chengman Wang, Jin Ouyang, Ting Luo, Fanfan Zeng, Yu Zhang, Liyun Gao, Shaoxin Huang, Xin Wang

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shiqun Yu *Yunfu Center for Disease Control and Prevention, Yunfu, China.
Chengman Wang *School of Public Health, Jiangxi Medical College, Nanchang University, Nanchang, 330006, China.
Jin OuyangJiangxi Key Laboratory of Molecular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Ting LuoInfection Control Center, The First Affiliated Hospital of Nanchang University, Nanchang, 330000, China.
Fanfan ZengSchool of Public Health, Jiangxi Medical College, Nanchang University, Nanchang, 330006, China.
Yu ZhangSchool of Public Health, Jiangxi Medical College, Nanchang University, Nanchang, 330006, China.
Liyun GaoJiangxi Provincial Key Laboratory of Cell Precision Therapy, School of Basic Medical Sciences , Jiujiang University, Jiujiang, 332005, Jiangxi, China.
Shaoxin HuangJiangxi Provincial Key Laboratory of Cell Precision Therapy, School of Basic Medical Sciences , Jiujiang University, Jiujiang, 332005, Jiangxi, China.
Xin WangJiangxi Provincial Key Laboratory of Cell Precision Therapy, School of Basic Medical Sciences , Jiujiang University, Jiujiang, 332005, Jiangxi, China. wangxin2813@163.com.

Funding

Jiangxi Provincial Natural Science Foundation 20224ACB206038
6 · The paper itself

Abstract

Breast cancer (BC) is the second leading cause of cancer-related death in females, followed by lung cancer. Disadvantages exist in conventional diagnostic techniques of BC, such as radiation risk. The present study integrated bioinformatics analysis with machine learning to elucidate potential key candidate genes associated with the tumorigenesis of BC. Eleven datasets were downloaded from the Gene Expression Omnibus (GEO) database and were consolidated into two independent cohorts (training cohort and validation cohort) after batch-effect removal. We employed "limma" package to screen differentially expressed genes (DEGs) between BC and adjacent normal breast samples. Subsequently, the most reliable diagnostic indicators were identified utilizing LASSO-Logistic regression, SVM-RFE and multivariate stepwise Logistic regression analysis. Logistic model and nomogram were created based on these hub genes and applied in external validation cohort to verify the robustness of the model. As a result, a total of six hub genes connected with BC pathogenesis were identified, including CD300LG, IGSF10, FAM83D, MAMDC2, COMP and SEMA3G. Then, a diagnostic model of BC on the basis of these genes was established. ROC analysis of the diagnostic model illustrated that AUC of the training cohort was 0.978 (0.962, 0.995). In the validation cohort, AUC of training set and validation set were 0.936 (0.910, 0.961) and 0.921 (0.870, 0.972), respectively. This indicated that the model was reliable in separating BC patients from healthy individuals. The model may assist in early diagnosis of BC with implications for improving the prognosis of BC patients.

Indexed as

Biomarkers, TumorBreast NeoplasmsComputational BiologyDatabases, GeneticFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticHumansMachine LearningNomogramsROC CurveBiomarkers, TumorBreast cancerDiagnosisDifferentially expressed genesGene expression omnibusLogistic regressionNomogram

Identifiers

PMID40082607
PMCPMC11906855

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.